NTG Nordic Transport Group

NeuroSearch is a biopharmaceutical company focused on the discovery, development and commercialization of new drugs targeting disease areas for which the existing treatment options are insufficient. Co. develops drugs which can improve the quality of life of patients and their relatives through the modulation of ion channels and monoamine systems in the brain.Co.'s work is primarily focused on disorders in the central nervous system (CNS). CNS diseases involve the fields of psychiatry and neurology. Among other things, Co. is working to find new drugs for the treatment of depression, Huntington's disease, ADHD, anxiety, psychoses, Alzheimer's disease, pain, Parkinson's disease and epilepsy.
  • TickerNTG
  • ISINDK0061141215
  • ExchangeNasdaq Nordic Copenhagen
  • SectorIndustrial Transportation
  • CountryDenmark

ResearchPool Subscriptions

Get the most out of your insights

Get in touch